Century Therapeutics IPSC Q1 2025 earnings
Reported May 15, 2025 · Before market open
Revenue estimate$41.3M
EPS estimate-$0.31
Next report
Aug 13, 2026 (in a month)Revenue estimate$2.2M
EPS estimate-$0.11
Versus estimates
Revenue
Q1 2025$109.2MBeat by $67.9M
Q4 2024$4.2MMiss by $45.4MDiluted EPS
Ask the moment Century Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Century Therapeutics report Q1 2025 earnings?
- Century Therapeutics (IPSC) reported Q1 2025 earnings on May 15, 2025 before market open.
- What were Century Therapeutics's Q1 2025 revenue and EPS?
- Century Therapeutics reported revenue of $109.2M and diluted EPS of $0.89 for Q1 2025.
- Did Century Therapeutics beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $41.3M by $67.9M. EPS beat the consensus estimate of $-0.31 by $1.20.
- How did Century Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 12667.7% from $855.0K a year earlier.
- Where can I find Century Therapeutics's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001558370-25-007885) directly on SEC EDGAR. The filing index links above go to sec.gov.